Apellis Pharmaceuticals Inc (APLS)
30.77
+3.02
(+10.88%)
USD |
NASDAQ |
Nov 22, 16:00
30.76
-0.01
(-0.03%)
After-Hours: 20:00
Apellis Pharmaceuticals Stock Buybacks (Quarterly): 0.00 for Sept. 30, 2024
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.00 |
| June 30, 2024 | 98.76M |
| March 31, 2024 | -98.76M |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | -384.39M |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | -380.12M |
| December 31, 2021 | -380.36M |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.17M |
| March 31, 2020 | -381.59M |
| December 31, 2019 | 0.048M |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.298M |
| March 31, 2019 | -109.93M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.131M |
| June 30, 2018 | -131.32M |
| March 31, 2018 | 0.00 |
| December 31, 2017 | -150.06M |
| September 30, 2017 | 0.00 |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-384.39M
Minimum
Mar 2023
98.76M
Maximum
Jun 2024
-76.31M
Average
--
Median
Sep 2020
Stock Buybacks (Quarterly) Benchmarks
| Biomarin Pharmaceutical Inc | -- |
| Ionis Pharmaceuticals Inc | -496.10M |
| EyePoint Pharmaceuticals Inc | -11.79M |
| Cassava Sciences Inc | -- |
| Macrogenics Inc | 0.00 |